Targeted therapies for gastric cancer: current status.
作者： Jaclyn Yoong , Michael Michael , Trevor Leong
DOI: 10.2165/11592530-000000000-00000
关键词:
摘要: Gastric cancer represents one of the most common cancers internationally. Unfortunately majority patients still present at an advanced stage, and despite advances in diagnostic treatment strategies, outcomes remain poor with high mortality rates a decline incidence.
springer.com
sci-hub.se 参考文章(174)
A Webb, D Cunningham, J H Scarffe, P Harper, A Norman, J K Joffe, M Hughes, J Mansi, M Findlay, A Hill, J Oates, M Nicolson, T Hickish, M O'Brien, T Iveson, M Watson, C Underhill, A Wardley, M Meehan, Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. Journal of Clinical Oncology. ,vol. 15, pp. 261- 267 ,(1997) , 10.1200/JCO.1997.15.1.261
Udo Vanhoefer, Philippe Rougier, Hansjochen Wilke, Michel P. Ducreux, Angel J. Lacave, Eric Van Cutsem, Manfred Planker, José Guimaraes Dos Santos, Pascal Piedbois, Bernard Paillot, Heinrich Bodenstein, Hans-Jochen Schmoll, Harry Bleiberg, Bernard Nordlinger, Marie-Laure Couvreur, Benoit Baron, Jacques A. Wils, Final Results of a Randomized Phase III Trial of Sequential High-Dose Methotrexate, Fluorouracil, and Doxorubicin Versus Etoposide, Leucovorin, and Fluorouracil Versus Infusional Fluorouracil and Cisplatin in Advanced Gastric Cancer: A Trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group Journal of Clinical Oncology. ,vol. 18, pp. 2648- 2657 ,(2000) , 10.1200/JCO.2000.18.14.2648
Gary K. Schwartz, Yuhong She, Francis Sirotnak, Carina Rizzo, Monica Motwani, Flavopiridol Enhances the Effect of Docetaxel in Vitro and in Vivo in Human Gastric Cancer Cells1 Molecular Cancer Therapeutics. ,vol. 2, pp. 549- 555 ,(2003)
Kaori Fujimoto-Ouchi, Fumiko Sekiguchi, Hideyuki Yasuno, Yoichiro Moriya, Kazushige Mori, Yutaka Tanaka, Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models. Cancer Chemotherapy and Pharmacology. ,vol. 59, pp. 795- 805 ,(2007) , 10.1007/S00280-006-0337-Z
Fernando Rivera, Maria Eugenia Vega-Villegas, Marta Francisca López-Brea, Cetuximab, its clinical use and future perspectives Anti-Cancer Drugs. ,vol. 19, pp. 99- 113 ,(2008) , 10.1097/CAD.0B013E3282F23287
Gun Hi Kang, Gwang Sil Kim, Hyo Rak Lee, Young Jin Yuh, Sung Rok Kim, None, A phase II trial of paclitaxel, 5-fluorouracil (5-FU) and cisplatin in patients with metastatic or recurrent gastric cancer. Cancer Research and Treatment. ,vol. 40, pp. 106- 110 ,(2008) , 10.4143/CRT.2008.40.3.106
A Ravaud, M Borner, JHM Schellens, L Geoffrois, BP Schöffski, K Kroon, J Wanders, AR Hanauske, P Fumoleau, EORTC—Early Clinical Studies Group, UFT and leucovorin in first-line chemotherapy for patients with metastatic gastric cancer. An Early Clinical Studies Group (ECSG)/European Organization for Research Treatment of Cancer (EORTC) phase II trial European Journal of Cancer. ,vol. 37, pp. 1642- 1647 ,(2001) , 10.1016/S0959-8049(01)00187-3
Yixing Jiang, Jaffer A Ajani, Multidisciplinary management of gastric cancer. Current Opinion in Gastroenterology. ,vol. 26, pp. 640- 646 ,(2010) , 10.1097/MOG.0B013E32833EFD9B
Hernán Cortés-Funes, The role of antiangiogenesis therapy: Bevacizumab and beyond Clinical & Translational Oncology. ,vol. 11, pp. 349- 355 ,(2009) , 10.1007/S12094-009-0368-0
Napoleone Ferrara, None, The role of vascular endothelial growth factor in pathological angiogenesis Breast Cancer Research and Treatment. ,vol. 36, pp. 127- 137 ,(1995) , 10.1007/BF00666035